Inventor · disambiguated record
Alfons Grunenberg
Also filed as: GRUNENBERG ALFONS
26 granted patents·9 pending applications·201 citations·filing 1995–2021
96Inventor score
Top patents by PatentIndex Score
35 records- 0193US9604948B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2015·Granted Mar 28, 2017·5 cites·8 claims
- 0291US11203593B2Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2020·Granted Dec 21, 2021·2 cites·22 claims
- 0390US10399977B2Process for preparing (4S)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as a pharmaceutical active ingredientBayer Pharma AG·Filed 2018·Granted Sep 3, 2019·7 cites·24 claims
- 0487US7713980B2Crystalline modifications of N-α-(2,4,6-triisopropyl-phenylsulfonyl)-3-hydroxyamidino-(L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereofWILEX AG·Filed 2005·Granted May 11, 2010·10 cites·19 claims
- 0585US9637459B2Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agentsAICURIS GMBH & CO KG·Filed 2013·Granted May 2, 2017·4 cites·20 claims
- 0684US8877933B2Thermodynamically stable form of a tosylate saltGRUNENBERG ALFONS·Filed 2005·Granted Nov 4, 2014·9 cites·31 claims
- 0784US8492385B2Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereofGRUNENBERG ALFONS·Filed 2010·Granted Jul 23, 2013·8 cites·9 claims
- 0884US8466280B2Co-crystal compound of rivaroxaban and malonic acidGRUNENBERG ALFONS·Filed 2009·Granted Jun 18, 2013·18 cites·11 claims
- 0982US10059707B2Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro- 1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredientBayer Pharma AG·Filed 2015·Granted Aug 28, 2018·3 cites·24 claims
- 1081US5830908ACrystalline hydrochloride of (R)-(-)-2-(N- 4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl-)-butyl!-aminomethyl)-chromanBAYER AG·Filed 1996·Granted Nov 3, 1998·62 cites·3 claims
- 1180US10633356B2Hydrates of substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·12 claims
- 1280US9340535B2N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrateAICURIS GMBH & CO KG·Filed 2012·Granted May 17, 2016·5 cites·25 claims
- 1379US12503469B2Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2021·Granted Dec 23, 2025·0 cites·5 claims
- 1479US5849752ACrystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modificationBAYER AG·Filed 1996·Granted Dec 15, 1998·46 cites·10 claims
- 1577US10087183B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2017·Granted Oct 2, 2018·1 cites·30 claims
- 1677US8188270B2Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamideGRUNENBERG ALFONS·Filed 2006·Granted May 29, 2012·4 cites·5 claims
- 1774US7977484B2Crystalline form of cyano-1-cyclopropy1-7-1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acidBAYER ANIMAL HEALTH GMBH·Filed 2005·Granted Jul 12, 2011·2 cites·3 claims
- 1872USRE49860EProcess for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredientBayer Pharma AG·Filed 2020·Granted Mar 5, 2024·0 cites·28 claims
- 1972US9957232B24-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrateGRUNENBERG ALFONS·Filed 2007·Granted May 1, 2018·2 cites·29 claims
- 2069US10364229B2Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparingADVERIO PHARMA GMBH·Filed 2017·Granted Jul 30, 2019·0 cites·3 claims
- 2166US10662188B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2018·Granted May 26, 2020·0 cites·30 claims
- 2263US8273876B2Medicaments containing vardenafil hydrochloride trihydrateSERNO PETER·Filed 2003·Granted Sep 25, 2012·3 cites·19 claims
- 2362US2015376184A1Forms of methyl methyl carbamateBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 2461USRE49575EMethod for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-l,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredientBayer Pharma AG·Filed 2015·Granted Jul 11, 2023·0 cites·24 claims
- 2552US8841446B2Medicaments containing vardenafil hydrochloride trihydrateBAYER IP GMBH·Filed 2012·Granted Sep 23, 2014·0 cites·15 claims
- 2649US2018194730A14-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrateBAYER IP GMBH·Filed 2018·Application pending·0 cites
- 2748US2011288174A1Monohydrate of 4-(phenyl)ethyl]-amino}methyl)benzoic acidGRUNENBERG ALFONS·Filed 2009·Application pending·0 cites
- 2848US2012010292A1Modification i of 4-(phenyl)ethyl]-amino}methyl)benzoic acidGRUNENBERG ALFONS·Filed 2009·Application pending·0 cites
- 2947US2011003829A1Enrofloxacin hexahydrateBAYER ANIMAL HEALTH GMBH·Filed 2008·Application pending·0 cites
- 3046US2010063112A1Polymorph iii of 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamideBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 3146US2010113533A1Polymorph II of 4-[4-(Amino)-3- Fluorophenoxy]-N-Methylpyridine-2-CarboxamideBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 3238US5599824APharmaceutical preparation containing a specific crystal modification of isopropyl-(2-methoxyethyl) 1,4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylateBAYER AG·Filed 1995·Granted Feb 4, 1997·5 cites·2 claims
- 3337US6362214B1Thermodynamically stable form of (R)-3-[[(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (ramatroban)BAYER YAKUHIN LTD·Filed 1998·Granted Mar 26, 2002·5 cites·6 claims
- 3437US2012316183A1Novel solvates of methylcarbamateGRUNENBERG ALFONS·Filed 2010·Application pending·0 cites
- 3537US2011183999A1Novel polymorphic forms of methyl carbamateBAYER SCHERING PHARMA AG·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →